Cardio Diagnostics Jumps After Launching Blood Test For Early Detection Of Coronary Heart Disease

On:

Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.

PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.

CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.

Source: Read Full Article

Lates News:
  1. U.S. Presidential Hopeful Robert F. Kennedy Jr. Brings Bitcoin to the Campaign Trail
  2. Bitcoin Poised for Explosive Growth to $190,000 After Crossing the $30,000 Threshold, Analyst Says
  3. Binance Research on How Bitcoin NFTs Are Taking the Crypto World by Storm
  4. Why Vitalik Buterin Is ‘Actually Kinda Happy a Lot of the ETFs Are Getting Delayed’
  5. Arthur Hayes Says BlackRock’s Bitcoin ETF Would Harm Decentralization